Month: July 2022

Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities

Staff July 6, 2022

Senior leadership realignment focused on continuing to deliver sales growth and enhanced profitability.EAGAN, MN / ACCESSWIRE / July 6, 2022...

MCOA Subsidiary cDistro Signs Master Distribution with Mellow to Distribute Dosist brand in Europe

Staff July 6, 2022

LOS ANGELES, CA / ACCESSWIRE / July 6, 2022 / Marijuana Company of America, Inc. (OTC:MCOA) ("the Company"), which operates,...

Clairvoyant Therapeutics: Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

Staff July 6, 2022

VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it...

Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference – Annual Revenue to PBI Expected to Exceed $1M

Staff July 6, 2022

Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A SessionSOUTH EASTON, MA / ACCESSWIRE / July 6,...

Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

Staff July 6, 2022

VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it...

Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

Staff July 6, 2022

ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary...

VUMC and Roivant Social Ventures Announce Collaboration to Develop Therapies for Underserved Populations

Staff July 6, 2022

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Vanderbilt University Medical Center (VUMC) and Roivant Social Ventures (RSV) announced an...

Teladoc Health Expands Innovative Whole-Person Primary Care Offering, Primary360

Staff July 6, 2022

New Capabilities and Clients are Fueling the Award-Winning Primary Care ServicePURCHASE, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:...

Better Choice Issues Shareholder Letter with Mid-Year Update on Recent Achievements

Staff July 6, 2022

NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a...

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Staff July 6, 2022

New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical OutcomesSANTA BARBARA, Calif., July 06, 2022 (GLOBE...

Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio

Staff July 6, 2022

This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)...

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

Staff July 6, 2022

CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on...

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

Staff July 6, 2022

Warwick, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC), is pleased to announce that it expects...

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

Staff July 6, 2022

Since launching in Western Canada in 2019, TELUS Health’s Personal Health Record (PHR) solution has seen rapid growth helping more...

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

Staff July 6, 2022

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects...

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

Staff July 6, 2022

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies...

Month: July 2022

Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities

MCOA Subsidiary cDistro Signs Master Distribution with Mellow to Distribute Dosist brand in Europe

Clairvoyant Therapeutics: Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

Pressure BioSciences to Expand on Upcoming Release of CBD Nanoemulsion Oral Spray at July 6th Emerging Growth Conference – Annual Revenue to PBI Expected to Exceed $1M

Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared

VUMC and Roivant Social Ventures Announce Collaboration to Develop Therapies for Underserved Populations

Teladoc Health Expands Innovative Whole-Person Primary Care Offering, Primary360

Better Choice Issues Shareholder Letter with Mid-Year Update on Recent Achievements

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

POINT Biopharma to Participate in Upcoming Investor Conferences

T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results

Zacks Places Share Value of ABVC BioPharma at $9.50

Quoin Pharmaceuticals Announces Opening of First Clinical Site for Netherton Syndrome Clinical Study

Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with Its CT 3500 Imaging Solution

LG EXPANDS MENTAL HEALTH SUPPORT FOR NCAA FINAL FOUR HOST SCHOOLS WITH NAMI PARTNERSHIP

Scarless MTF Breast Augmentation Performed by Seattle Plastic Surgeon

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease

BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS

You may have missed